Vivold Consulting

Function Health secures $298M to expand its AI-powered medical intelligence platform

Key Insights

Function Health has raised $298M at a $2.5B valuation to scale its AI-driven health insights platform. The funding will accelerate clinical model development and support expansion into new diagnostics categories. The company is positioning AI as a proactive health management companion.

Stay Updated

Get the latest insights delivered to your inbox

Function Health scales its medical intelligence ambitions


The company is building AI systems that turn raw diagnostics and lab data into actionable insights for patients and clinicians.

What the new capital supports


- Expansion of diagnostic coverage and biomarker analysis.
- More advanced clinical reasoning models.
- Scaling of partner integrations with care providers.

Why Function Health is attracting major investment


- Positioned at the intersection of AI and preventive medicine.
- Strong consumer adoption driven by personalized health analytics.
- Increasing appetite for AI-based longitudinal health tracking.

Why it matters


- AI becomes a key tool for early detection and monitoring.
- Could shift consumer expectations for continuous health management.
- Signals strong investor confidence in AI-enabled medical intelligence.

Related Articles

An AWS knowledge-graph deployment turned 6-month research cycles into 3 weeks - and the blueprint transfers far beyond pharma

An AWS GraphRAG deployment in pharmaceutical research cut R&D cycles by 87% - initial discovery that took six months now closes in three weeks - by fusing siloed internal databases and public literature into one queryable knowledge graph on Amazon Neptune Analytics and Bedrock (running Claude). Every answer comes with verifiable citations and a mapped reasoning path, which is exactly what regulated industries need for compliance. The architecture is modular and, crucially, transferable: any enterprise drowning in fragmented legacy data can copy this pattern.

SpaceX, Anthropic, and OpenAI listings will out-value every US VC-backed exit since 2000 - reshaping vendor economics for everyone

The new NVCA-Pitchbook Venture Monitor dropped a stunning claim: the pending OpenAI and Anthropic IPOs, together with SpaceX's listing, will generate more value than every US VC-backed exit since 2000 combined. SpaceX is already public at $1.77 trillion, and with both AI labs pushing toward trillion-dollar debuts, the trio should land north of $4 trillion - against roughly $70 billion in total US IPO proceeds last year. For anyone buying AI services, the labs' shift to public-market scrutiny will reshape pricing, transparency, and vendor stability.

A 14-person open-source team just became the default way 8.9M developers run local AI - and a lever for slashing inference bills

Ollama, the open-source tool that lets developers run open-weight AI models on their own machines in minutes, raised a $65M Series B led by Theory Ventures ($88M total), revealing it now serves 8.9 million developers monthly and sits inside 85% of the Fortune 500 - with just 14 employees. Founders Jeff Morgan and Michael Chiang previously built Docker Desktop, and they're repeating the play: abstract away the hardware pain, then monetise a cloud tier priced on GPU time rather than tokens. The backdrop is the industry's loudest cost debate: every company with heavy inference bills is under existential pressure to shift routine workloads to open models.